URL has been copied successfully!
U.S. stocks were lower, with the Nasdaq Composite falling around 100 points on Monday.
Shares of Nektar Therapeutics (NASDAQ:NKTR) rose sharply after the company announced results from a blinded 16-week treatment extension period in its Phase 2b REZOLVE-AA study.
The company said the REZOLVE-AA extension results demonstrated continued improvement in patients with severe-to-very-severe alopecia areata treated with rezpegaldesleukin, with responses strengthening over time across key SALT (Severity of Alopecia Tool) measures.
Nektar Therapeutics shares climbed 18.8% to $100.88 on Monday.
Here are some other big stocks recording gains in today’s session.
- AEVEX Corp (NYSE:AVEX) shares jumped 40% to $37.70. The shares gained momentum from the recent debut of the company on the NYSE.
- Compass Pathways PLC (NASDAQ:CMPS) gained 38.3% to $9.14 after President Donald Trump issued an executive order on Saturday instructing health regulators to hasten the review process of psychedelic drugs.
- AtaiBeckley Inc (NASDAQ:ATAI) rose 30.6% to $5.26 after …
Please follow us:
This post was originally published here
